CME Group Inc. $CME Stock Purchased by Kintegral Advisory LLC

Key Points

• Kintegral Advisory LLC increased its CME Group stake by 608.2% in the third quarter, ending with 52,901 shares valued at approximately $13.9 million. Institutional investors collectively own 87.75% of the company.
• CME Group shares rose 1.5% to $293.87, near the analyst consensus price target of $292.94. The company reported quarterly EPS of $2.99 and revenue of $1.71 billion, both exceeding analyst expectations.
• CME Group maintains a quarterly dividend of $1.30, equivalent to $5.20 annually and a 1.8% yield. Analyst sentiment is mixed, with nine Buy, six Hold, and three Sell ratings, producing an overall “Hold” consensus.

Kintegral Advisory LLC raised its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 608.2% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 52,901 shares of the financial services provider's stock after purchasing an additional 45,431 shares during the period. CME Group accounts for approximately 1.0% of Kintegral Advisory LLC's holdings, making the stock its 23rd biggest holding. Kintegral Advisory LLC's holdings in CME Group were worth $13,859,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of the business. BlackRock Inc. bought a new stake in shares of CME Group during the second quarter worth approximately $6,749,965,000. Bank of America Corp DE lifted its holdings in CME Group by 39.1% in the first quarter. Bank of America Corp DE now owns 4,019,944 shares of the financial services provider's stock valued at $1,187,290,000 after buying an additional 1,130,587 shares during the period. Bank of New York Mellon Corp acquired a new position in CME Group in the second quarter valued at approximately $867,313,000. Alphabet Inc. bought a new position in CME Group in the second quarter valued at approximately $769,376,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in CME Group in the second quarter valued at approximately $629,771,000. Institutional investors own 87.75% of the company's stock.

CME Group Trading Up 1.5%

CME Group stock traded up $4.41 during midday trading on Friday, hitting $293.87. 2,180,230 shares of the stock were exchanged, compared to its average volume of 1,887,081. The company has a fifty day simple moving average of $274.12 and a two-hundred day simple moving average of $270.77. CME Group Inc. has a 52 week low of $218.31 and a 52 week high of $329.16. The stock has a market capitalization of $105.67 billion, a PE ratio of 24.93, a P/E/G ratio of 3.79 and a beta of 0.24. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.91 by $0.08. The firm had revenue of $1.71 billion during the quarter, compared to analysts' expectations of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The business's revenue for the quarter was up .8% on a year-over-year basis. During the same quarter in the previous year, the company earned $2.96 earnings per share. Equities research analysts anticipate that CME Group Inc. will post 12.29 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 25th. Investors of record on Wednesday, September 9th were given a $1.30 dividend. The ex-dividend date was Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.8%. CME Group's dividend payout ratio is currently 44.11%.

Insider Buying and Selling

In other CME Group news, Director William Shepard acquired 293 shares of the company's stock in a transaction that occurred on Friday, September 25th. The shares were acquired at an average price of $268.76 per share, with a total value of $78,746.68. Following the purchase, the director owned 263,289 shares of the company's stock, valued at $70,761,551.64. This represents a 0.11% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Elizabeth Cook sold 500 shares of CME Group stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $280.11, for a total value of $140,055.00. Following the transaction, the director owned 17,916 shares in the company, valued at approximately $5,018,450.76. This represents a 2.72% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.30% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of analysts have commented on the stock. Wells Fargo & Company lifted their target price on shares of CME Group from $301.00 to $315.00 and gave the stock an "overweight" rating in a report on Wednesday. TD Cowen increased their price target on CME Group from $292.00 to $300.00 and gave the company a "buy" rating in a research note on Monday, October 5th. Deutsche Bank Aktiengesellschaft downgraded CME Group from a "buy" rating to a "hold" rating and cut their price target for the company from $286.00 to $270.00 in a research note on Wednesday, August 19th. Piper Sandler reduced their price target on CME Group from $329.00 to $295.00 and set an "overweight" rating on the stock in a research report on Wednesday, July 15th. Finally, JPMorgan Chase & Co. lifted their price objective on CME Group from $249.00 to $250.00 and gave the stock an "underweight" rating in a research note on Thursday, July 23rd. Nine investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have assigned a Sell rating to the company. Based on data from MarketBeat.com, CME Group currently has an average rating of "Hold" and a consensus target price of $292.94.

CME Group Profile

CME Group Inc operates global derivatives marketplaces that enable customers to manage risk and trade futures and options contracts. Its exchanges offer products linked to interest rates, equity indexes, foreign currencies, agricultural commodities, energy, metals and other asset classes.

The company also provides central counterparty clearing, settlement and related risk-management services for transactions conducted on its markets. In addition, CME Group offers market data, benchmark products and technology services that support trading, analysis and connectivity for financial institutions, businesses, professional traders and other market participants.

CME Group's history includes the Chicago Board of Trade, founded in 1848, and the Chicago Mercantile Exchange, established in 1898.

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.